MIT Research Team Develops Micro-Injection Pill to Deliver Oral Insulin

글 내용 전체보기

Sangamo Shares Fall After Preliminary Gene Editing Data Only Shows Slight Benefit

글 내용 전체보기

Despite Financial Losses, Seattle Genetics CEO Banks on Assets to Drive a Strong 2019

글 내용 전체보기

Expansion Projects Provide New Job Openings for Biotech Companies

글 내용 전체보기

Gossamer Bio, After a Game of Government Shutdown Roulette, Wins Big with $276 Million IPO

글 내용 전체보기

Report Shows Life Science Companies Continue to Be a Favorite Target of Securities Fraud Class Action Lawsuits

글 내용 전체보기

Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research

글 내용 전체보기

Amgen Doubles Down on Helping Patients with Multiple Myeloma

글 내용 전체보기

How to trump the Trump administration? For J&J, it’s putting list prices in ads before it’s forced to

글 내용 전체보기

FiercePharmaAsia—Takeda earnings and hemophilia patent; Chinese investors back cancer startup

글 내용 전체보기

Drug costs soaring? Express Scripts says 2018 growth was lowest in 25 years

글 내용 전체보기

Doctor payments drove scripts for cancer drugs from Pfizer, Novartis and more: study

글 내용 전체보기

Rebounding Teva is ‘too cheap to ignore,’ upbeat analysts say

글 내용 전체보기

Philly council nixes pharma gift ban, sales rep rules

글 내용 전체보기

Chutes & Ladders—Chimerix CEO replaced by a trio of officers

글 내용 전체보기

UniQure’s hemophilia B gene therapy clears another clinical test

글 내용 전체보기

New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts

글 내용 전체보기

Sangamo sinks as genome editing flunks early clinical test

글 내용 전체보기

Renamed Axovant could see big gains in 2019: analysts

글 내용 전체보기

How a decades-old HIV drug might help treat Alzheimer’s, age-related diseases

글 내용 전체보기

Roche looks to delivery device to keep Lucentis biosimilars at bay

글 내용 전체보기